- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1-4 cm renal cell carcinomas.
November 12, 2020
Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma.
November 11, 2020
[Renal cell carcinoma in the department of Hérault: Results over a 30 year period].
November 11, 2020
Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database.
November 11, 2020
Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
November 10, 2020
Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells.
November 9, 2020
MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma.
November 9, 2020
Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.
November 9, 2020
Identified a Biomarker That Predicts the Increase in Malignancy That Antiangiogenic Therapy Can Cause in Kidney Cancers
November 6, 2020
Kidney Cancer PDOXs Reveal Patient‐specific Pro‐malignant Effects of Antiangiogenics and Its Molecular Traits
November 6, 2020
Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma.
November 6, 2020
Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma.
November 6, 2020